Abstract:Abstract There has been an increasing role in the use of injectable fillers for rejuvenation of the aging face. In this systematic review, we aim to evaluate the existing literature related to soft tissue fillers of the midface. Specifically, we focus on the non-hyaluronic acid fillers including polymethylmethacrylate (PMMA), poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and autologous fat. A systematic review was conducted in November 2020 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines with PubMed and Embase databases. Medical Subject Headings terms used were “cheek” OR “midface” OR “malar” and “filler” OR “poly-L-lactic acid” OR “calcium hydroxyapatite,” “autologous fat” OR “polymethylmethacrylate” OR “Artefill” OR “Bellafill” OR “Radiesse” OR “Sculptra.” The initial search identified 271 articles. After 145 duplicates were removed, 126 studies were screened for relevance by title and abstract. A total of 114 studies were eliminated based on inclusion and exclusion criteria. Twelve articles underwent full-text review. Seven articles were included in the final analysis consisting of four non-hyaluronic filler products: PMMA, PLLA, CaHA, autologous fat. Most patients were highly satisfied with their results. Due to the gradual volumizing effects of PMMA, PLLA, and CaHA, patient satisfaction generally improved over time. Minor adverse reactions related to treatment included bruising, swelling, and pain. Nodule formation was reported in PLLA and CaHA studies. For autologous fat, 32% of the original injection volume remained at 16 months post-treatment, which still provided clinically improved malar enhancement. Dermal fillers are an attractive treatment option for the aging face due to their high patient satisfaction, long-lasting effects, and low side-effect profile. Patients should be appropriately counseled on the delayed effects of non-HA fillers. Autologous fat is a good option in many patients with the major drawback of unpredictable longevity, which may require a secondary procedure. Future studies should examine the longevity and long-term side effects of these fillers.

Volumizing Fillers for Skin: Selection Strategies

Parotidectomy: Ten-Year Review of 237 Cases at a Single Institution

B‐Cell‐Dependent Memory T Cells Impede Nonmyeloablative Mixed Chimerism Induction in Presensitized Mice

Midface Volumization with Injectable Fillers

Permanent Facial Fillers: Addressing Complications and Advancing Solutions

Natural history of intramural hematoma of the descending thoracic aorta.

Collagen-Containing Fillers: Alone and in Combination

Injectable soft-tissue fillers: clinical overview

Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products)

The Role of Clinical Examination in Midface Volume Correction Using Hyaluronic Acid Fillers: Should Patients Be Stratified by Skin Thickness?

In Vitro Cytocompatibility Analysis and Comparison of Different Hyaluronic Acid Fillers for Minimally Invasive Esthetics

Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review

Soft-Tissue Augmentation and the Role of Poly-L-Lactic Acid

Objective Noninvasive Measurement of the Volumizing Effect of a Dermal Filler: An In Vivo Study

Modeling of five-level symmetric flying capacitor multilevel inverter for STATCOM application

The role of androgens in the effect of diabetes mellitus on hepatic drug metabolism in the male rat.

Intracorporeal evaluation of hyaluronic acid fillers with varied rheological properties and correlations with aesthetic outcomes

Myomodulation with Facial Fillers: A Comprehensive Technical Guide and Retrospective Case Series

Facial Soft-Tissue Augmentation with Injectable Autologous and Allogeneic Human Tissue Collagen Matrix (Autologen and Dermalogen)

The biology of facial fillers

In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen